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Figure 1. Multiple Mutational Pathways for Fold Switching
Crossing back and forth between 3a (left) and 4b+a (right) folds via a series of
single amino-acid substitutions at different positions in the protein sequence.
Shaded boxes represent sequences encoding the 3a fold; open boxes repre-
sent sequences encoding the 4b+a fold.
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PreviewsExamples of fold change in
design, mutagenesis, func-
tion, and evolution involve
different degrees of topolog-
ical change, ranging from
substitutions of one or two
secondary structure elements
to replacement of entire
subdomains, to wholesale
domain remodeling (Bryan
and Orban, 2010). Designs,
including those of He et al.
(2012) on the protein G
domains, often involve more
dramatic, comprehensive re-
arrangements than natural
fold switches. Although artifi-cial in nature, these designed systems
have a great deal to tell us about the plau-
sibility of large-scale structural changes
aswell as potential pathways of sequence
change connecting structures. He et al.
(2012) note that adistant evolutionary rela-
tionship between GA and GB remains
possible. The NusG/RfaH system is an
apparent case of a complete structural
rearrangement in natural domain fold
evolution (Belogurov et al., 2007).
He et al. (2012) and many other switch
and chameleon design studies (Ander-
son et al., 2011; Ambroggio and Kuhl-
man, 2006) utilize mostly or entirely the
binary sequence space defined by
a pair of aligned protein sequences.200 Structure 20, February 8, 2012 ª2012 ElsBecause actual sequence space is vastly
larger, these proteins are designed with
one proverbial hand tied behind the
back. Considering the expanded possi-
bilities inherent in higher dimensional
explorations of sequence space (Am-
broggio and Kuhlman, 2006), and given
the increasing number of examples of
natural fold switching, the future seems
wide open. The fog is lifting to reveal
the beautiful and rugged, yet passable,
borderlands of the protein universe.
Some proteins may stay clear of the
marchlands during their evolutionary
travels; others may wander through; still
others may remain in these in-between
places.evier Ltd All rights reservedREFERENCES
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The four serotypes of dengue virus present a formidable challenge for the development of efficacious human
vaccines. Cockburn and colleagues, in this issue of Structure, describe the structural basis of a cross-
reactive neutralizing antibody, providing greater insight into immune protection and pathogenesis.Dengue virus (DENV) is a mosquito-borne
member of the flavivirus genus respon-
sible for roughly 50 million human infec-
tions each year. Four antigenically-related
serotypes of DENV circulate in tropicaland subtropical regions of the globe.
Infection by any of the four DENV sero-
types may cause a self-limiting febrile
illness that is rarely fatal, and is thought
to confer immunity to reinfection by thesame serotype of DENV. However, the
secondary infection of a DENV-seroposi-
tive individual with a heterologous DENV
serotype may lead to more severe clini-
cal manifestations of disease, including
Figure 1. Dynamic States of the Dengue Virion
The Ca backbone of E proteins from the uncomplexed mature DENV (left), through to the mAb complex structure (right), showing the potential transition (middle
three structures). The complex structure (right) is taken from virus bound to Fab 1A1D-2. Binding of 4E11 is expected to capture a similar rearrangement of
E proteins. The black triangle represents the asymmetric unit of the virus. E-DI, E-DII, and E-DIII are colored red, yellow, and blue, respectively. Note that
E-DIII moves the least, but its surroundings become less crowded with adjacent subunits.
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Previewshemorrhage and shock. The increased
hyperendemicity of DENV inmany regions
of the globe has resulted in a dramatic
increase in the number of severe DENV
cases each year. The immunological
mechanisms responsible for the more
aggressive disease following the sec-
ondary infection of DENV-immune indi-
viduals is incompletely understood and
may involve both arms of the adap-
tive immune response (Rothman, 2011).
DENV-reactive antibodies are thought to
contribute to not only protection from
infection but also to exacerbated disease
following secondary infections. Antibody-
dependent enhancement of infection
describes the more efficient infection of
Fcg-receptor-expressing cells in the pres-
ence of DENV-reactive antibodies and
may contribute to severe disease (Kliks
et al., 1989). While vaccines that protect
against DENV are urgently needed, their
development is complicated by a require-
ment to simultaneously protect against all
four serotypes of DENV (Whitehead et al.,
2007). Thus, understanding the molecular
basis for the recognition of DENV by ho-
mologous and cross-reactive antibodies
is critical for understanding factors that
contribute to pathogenesis.
The envelope (E) protein is an elongated
three domain structure incorporated into
virus particles that orchestrates the
attachment and entry of virions into cells
(Mukhopadhyay et al., 2005). The majority
of anti-flavivirus neutralizing antibodies
recognize epitopes contained within or
between the three domains of the E
protein (Pierson et al., 2008). In this issue
of Structure, Cockburn and colleagues
(2012) present exciting new structural
insights into the recognition of DENV
by a murine monoclonal antibody (mAb)capable of neutralizing all four serotypes
of DENV. mAb 4E11 is a well-character-
ized cross-reactive murine mAb raised
against DENV1 that binds domain III
(E-DIII) of the E protein. Biochemical
analysis of the binding of this mAb to re-
combinant variants of E-DIII of DENV1
identified nine residues that significantly
impact antibody recognition (Lisova
et al., 2007). These critical residues map
to the A- and G- b strands that form the
edge of E-DIII b-sandwich and have
been shown to be involved the recogni-
tion of many group-reactive anti-flavivirus
antibodies (Sukupolvi-Petty et al., 2007).
The structure of 4E11 in complex with
E-DIII from all four serotypes of DENV
now described extends these studies by
defining how variation in the 4E11 epitope
among DENV strains modulates antibody
binding and neutralization. 4E11 binds
each DENV serotype in a similar manner
via interactions with residues on the A-
andG-strands surrounding a hydrophobic
core region of E-DIII. These studies
identify the conserved residues required
for cross-reactivity among DENV strains
as well as the contribution of more vari-
able side chains toward the marked
difference in binding affinity among
DENV serotypes. Of significant interest,
the relative position of 4E11 in complex
with E-DIII from each DENV serotype
reveals that the antibody shifts position
on the A-strand epitope to accommodate
the nonconserved residues among DENV
strains. This raises the intriguing possi-
bility that subtle differences in the angle
of antibody engagement of an epitope
may translate into substantial differences
in the interaction of intact antibody mole-
cules with the virus particle and in what
numbers.Structure 20, February 8, 2012Onmature DENV virions, 180 E proteins
are arranged as rafts of antiparallel dimers
organized in an unusual herringbone
pattern (Mukhopadhyay et al., 2005).
This dense arrangement imposes steric
constraints for antibody recognition on
the intact virion (Pierson et al., 2008).
The A-strand epitope recognized by
mAb 4E11 is not predicted to be acces-
sible on the mature virion. The distal end
of E domain II (E-DII) encodes a highly
conserved hydrophobic fusion loop that
is required for viral membrane fusion. On
mature virions, the fusion loop packs
into the hydrophobic pocket adjacent to
the A-strand of E-DIII on the opposing E
protein of a dimer. The E-DIII residue
that coordinates this interaction is a crit-
ical contact for 4E11. Thus, the binding
of 4E11 requires displacement of the
fusion loop away from the dimer interface.
So how does 4E11 bind the virion?
Proteins incorporated into flaviviruses
are in constant motion as they sample
related conformations at equilibrium. Our
understanding of the ensemble of confor-
mations sampled by the virion is incom-
plete but has been greatly informed by
studies with antibodies in complex with
virions. 1A1D-2 is a DENV group-reactive
mAb that shares 85% amino acid iden-
tity with 4E11, binds the same A-strand
epitope, and is capable of neutralizing
DENV 1, 2, and 3 (Lok et al., 2008).
Binding of 1A1D-2 to virus particles is
temperature-dependent. Cryo-electron
microscopic reconstructions of 1A1D-2
in complex with DENV suggested this
antibody binds the virion by trapping
a conformation not predicted by the exist-
ing structural models of the mature DENV
structure (Figure 1) (Mukhopadhyay et al.,
2005). Presumably, 1A1D-2 and 4E11ª2012 Elsevier Ltd All rights reserved 201
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Previewsbind and stabilize the A-strand epitope as
it becomes accessible on the surface of
a ‘‘breathing’’ virion. In agreement, a re-
cent study suggested that time- and
temperature-dependent effects on anti-
body-mediated neutralization may be a
common feature of anti-flavivirus anti-
bodies (Dowd et al., 2011). The contribu-
tion of structural dynamics on the sero-
type-dependent interactions between
4E11 and DENV remains unexplored.
Virion breathing may have significant
consequences not only for antibody re-
cognition, but also for receptor binding
and virion disassembly. As Cockburn
and colleagues (2012) speculate, if the
four DENV serotypes bind to the same
receptor, they have already identified a
potential common binding site on the
E protein for such a receptor interaction.
Under physiological conditions, the site
would be transiently accessible and could
be captured by a cellular receptor. The
proximity of this site on the A-strand of
DIII to the fusion loop suggests that this202 Structure 20, February 8, 2012 ª2012 Elshydrophobic sequence may become ex-
posed at the cell surface, analogous to
what has been proposed for alphaviruses
(Meyer and Johnston, 1993). This capture
event by a cellular receptor might irrevers-
ibly bind the virus to the cell and promote
the subsequent fusion and disassembly of
the virion. Taken together, these and pre-
vious studies suggest that understanding
the molecular mechanisms of antibody-
virus binding may provide much broader
biological insights than simply antibody-
mediated neutralization.REFERENCES
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In this issue of Structure, Choi et al. use hydrogen/deuterium exchange mass spectrometry to characterize
a Notch transcription complex (NTC). When interpreted in the context of NTC X-ray structures, their findings
reveal important molecular insights into the dynamics that underlie complex assembly.Proteins are dynamic—during their life-
times, they fold, unfold, and refold; some
secondary structural elements are flexible
and unravel, while others remain more
rigid, and hydrogen bonds are formed
and broken during these frenetic pro-
cesses. Moreover, the dynamic nature
of proteins is often important for un-
derstanding function, including enzyme
catalysis, disorder-to-order transitions,
and assembly of multimeric protein com-
plexes. Although X-ray structures un-
questionably provide a wealth of high-
resolution structural information about
proteins, typically these data providea static view of the structure and pro-
vide little to no insight into protein dyn-
amics. However, when crystallographic
data is combined with other biophysical
methods that probe protein dynamics,
such as hydrogen/deuterium exchange
mass spectrometry (HX-MS), this often
leads to significant molecular insights
that either technique alone would unlikely
glean.
Hydrogen/deuterium exchange meth-
ods provide information on the backbone
amide hydrogen atoms in the protein and
whether these hydrogens can exchange
with deuterium in the D2O containingsolvent during the time course of the ex-
periment (Englander and Mayne, 1992).
If the backbone amide hydrogen is en-
gaged in a hydrogen bond, e.g., in the
secondary structural elements a helix
or b sheet, then it is protected from ex-
change. Thus, hydrogens both on the
protein surface and buried within the
protein interior can experience protection
from exchange. However, if the hydrogen
bond is broken during the time course of
the experiment, due to local or global
perturbations in protein structure, and
the backbone amide is exposed to sol-
vent, then the hydrogen will undergo
